- Home
- NERV vs CCTG Comparison
NERV vs CCTG Comparison
Compare NERV & CCTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- CCTG
- Stock Information
- Founded
- NERV 2007
- CCTG 1993
- Country
- NERV United States
- CCTG Hong Kong
- Employees
- NERV N/A
- CCTG N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- CCTG
- Sector
- NERV Health Care
- CCTG
- Exchange
- NERV Nasdaq
- CCTG Nasdaq
- Market Cap
- NERV 14.6M
- CCTG 12.7M
- IPO Year
- NERV 2014
- CCTG 2024
- Fundamental
- Price
- NERV $2.83
- CCTG $2.34
- Analyst Decision
- NERV Hold
- CCTG
- Analyst Count
- NERV 1
- CCTG 0
- Target Price
- NERV $5.00
- CCTG N/A
- AVG Volume (30 Days)
- NERV 639.5K
- CCTG 790.1K
- Earning Date
- NERV 11-04-2025
- CCTG 09-26-2025
- Dividend Yield
- NERV N/A
- CCTG N/A
- EPS Growth
- NERV N/A
- CCTG N/A
- EPS
- NERV 1.48
- CCTG N/A
- Revenue
- NERV N/A
- CCTG $17,631,489.00
- Revenue This Year
- NERV N/A
- CCTG N/A
- Revenue Next Year
- NERV N/A
- CCTG N/A
- P/E Ratio
- NERV $1.47
- CCTG N/A
- Revenue Growth
- NERV N/A
- CCTG 19.55
- 52 Week Low
- NERV $1.15
- CCTG $0.99
- 52 Week High
- NERV $3.29
- CCTG $3.17
- Technical
- Relative Strength Index (RSI)
- NERV 70.41
- CCTG 77.01
- Support Level
- NERV $2.06
- CCTG $1.04
- Resistance Level
- NERV $2.15
- CCTG $1.40
- Average True Range (ATR)
- NERV 0.11
- CCTG 0.27
- MACD
- NERV 0.02
- CCTG 0.11
- Stochastic Oscillator
- NERV 70.72
- CCTG 96.79
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About CCTG CCSC Technology International Holdings Limited
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.